phosphatidylcholines has been researched along with amphotericin b, deoxycholate drug combination in 21 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (amphotericin b, deoxycholate drug combination) | Trials (amphotericin b, deoxycholate drug combination) | Recent Studies (post-2010) (amphotericin b, deoxycholate drug combination) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 331 | 29 | 156 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (23.81) | 18.2507 |
| 2000's | 16 (76.19) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhamra, R; Bolcsak, LE; Janoff, AS; Sa'ad, A; Swenson, CE | 1 |
| Evans, ME; Gubbins, PO; Rapp, RP | 1 |
| García Garmendia, JL; Garnacho-Montero, J; Jiménez Jiménez, F; Ortiz-Leyba, C | 1 |
| Carrillo-Muñoz, AJ; Cossum, PA; del Valle, O; Miranda, Y; Quindós, G; Ruesga, MT; Tur, C; Wallace, TL | 1 |
| Rex, JH; Walsh, TJ | 1 |
| Kennedy, AL; Peteherych, KD; Ramaswamy, M; Wasan, KM | 1 |
| Kontoyiannis, DP; Mantadakis, E; Samonis, G | 1 |
| Cannon, JP; Danziger, LH; De Alba, F; Edward, DP; Fiscella, R; Garey, KW; Pattharachayakul, S; Piscitelli, S | 1 |
| Mehta, H; Murray, HW; Rai, M; Singh, SP; Sundar, S; Suresh, AV | 1 |
| Benjamin, DK; Dodds Ashley, E; Drew, RH; Duane Davis, R; Palmer, SM; Perfect, JR | 1 |
| Murray, HW | 1 |
| Perfect, JR | 1 |
| Avorn, J; Fischer, MA; Rubin, RH; Winkelmayer, WC | 1 |
| Leather, H; Wingard, JR | 1 |
| Armstrong, D; Lyman, CA; Petraitiene, R; Roilides, E; Stergiopoulou, T; Walsh, TJ | 1 |
| Kleinberg, M | 1 |
| Drew, R | 1 |
| Olin, JL; Spooner, LM | 1 |
| Alfaro, RM; Armstrong, D; Bacher, J; Groll, AH; Lyman, CA; Mickiene, D; Petraitiene, R; Petraitis, V; Schaufele, RL; Sein, T; Walsh, TJ | 1 |
| Mert, A; Mete, B; Ozaras, R; Ozturk, R; Tabak, F; Yemisen, M | 1 |
| Frank, M; Jaradeh, SS; Ortega-Gutierrez, S; Szeder, V | 1 |
6 review(s) available for phosphatidylcholines and amphotericin b, deoxycholate drug combination
| Article | Year |
|---|---|
Amphotericin B lipid complex.
Topics: Amphotericin B; Animals; Antifungal Agents; Deoxycholic Acid; Drug Combinations; Humans; Mycoses; Phosphatidylcholines; Phosphatidylglycerols | 1997 |
Systemic mycoses in the immunocompromised host: an update in antifungal therapy.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Candidiasis; Deoxycholic Acid; Drug Combinations; Echinocandins; Fungal Proteins; Humans; Immunocompromised Host; Mycoses; Peptides; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Triazoles | 2003 |
Progress in the treatment of a neglected infectious disease: visceral leishmaniasis.
Topics: Amphotericin B; Antimony; Antiprotozoal Agents; Clinical Trials as Topic; Deoxycholic Acid; Drug Combinations; Drug Costs; Humans; Leishmaniasis, Visceral; Paromomycin; Phosphatidylcholines; Phosphatidylglycerols; Phosphorylcholine; Practice Guidelines as Topic | 2004 |
Use of newer antifungal therapies in clinical practice: what do the data tell us?
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Liposomes; Mycoses; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis | 2004 |
What is the current and future status of conventional amphotericin B?
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Chemistry, Pharmaceutical; Colloids; Deoxycholic Acid; Drug Combinations; Humans; Liposomes; Phosphatidylcholines; Phosphatidylglycerols; Treatment Outcome | 2006 |
Potential role of aerosolized amphotericin B formulations in the prevention and adjunctive treatment of invasive fungal infections.
Topics: Aerosols; Amphotericin B; Antifungal Agents; Chemistry, Pharmaceutical; Deoxycholic Acid; Drug Combinations; Humans; Incidence; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Treatment Outcome | 2006 |
2 trial(s) available for phosphatidylcholines and amphotericin b, deoxycholate drug combination
| Article | Year |
|---|---|
Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations.
Topics: Adolescent; Adult; Amphotericin B; Animals; Antiprotozoal Agents; Child; Child, Preschool; Deoxycholic Acid; Drug Combinations; Drug Costs; Female; Hospital Costs; Humans; India; Infant; Leishmaniasis, Visceral; Liposomes; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Treatment Outcome | 2004 |
Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients.
Topics: Adolescent; Adult; Aerosols; Aged; Amphotericin B; Deoxycholic Acid; Double-Blind Method; Drug Combinations; Female; Heart-Lung Transplantation; Humans; Lung Diseases; Lung Transplantation; Male; Middle Aged; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Postoperative Complications; Racial Groups; Retrospective Studies | 2004 |
13 other study(ies) available for phosphatidylcholines and amphotericin b, deoxycholate drug combination
| Article | Year |
|---|---|
Behavior of amphotericin B lipid complex in plasma in vitro and in the circulation of rats.
Topics: Amphotericin B; Animals; Antifungal Agents; Cholesterol; Chromatography, High Pressure Liquid; Deoxycholic Acid; Drug Combinations; Male; Phosphatidylcholines; Phosphatidylglycerols; Rats; Rats, Sprague-Dawley | 1997 |
Life-threatening adverse event after amphotericin B lipid complex treatment in a patient treated previously with amphotericin B deoxycholate.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Deoxycholic Acid; Drug Combinations; Humans; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Respiration Disorders | 1998 |
In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole.
Topics: Amphotericin B; Antifungal Agents; Candida; Deoxycholic Acid; Drug Carriers; Drug Combinations; Fluconazole; Humans; Itraconazole; Liposomes; Microbial Sensitivity Tests; Nystatin; Phosphatidylcholines; Phosphatidylglycerols | 1999 |
Estimating the true cost of amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Cost-Benefit Analysis; Deoxycholic Acid; Drug Combinations; Humans; Phosphatidylcholines; Phosphatidylglycerols | 1999 |
Amphotericin B lipid complex or amphotericin B multiple-dose administration to rabbits with elevated plasma cholesterol levels: pharmacokinetics in plasma and blood, plasma lipoprotein levels, distribution in tissues, and renal toxicities.
Topics: Amphotericin B; Animals; Antifungal Agents; Cholesterol; Creatinine; Deoxycholic Acid; Drug Combinations; Hypercholesterolemia; Kidney; Kinetics; Lipoproteins; Phosphatidylcholines; Phosphatidylglycerols; Rabbits; Tissue Distribution | 2001 |
Comparative toxicity and concentrations of intravitreal amphotericin B formulations in a rabbit model.
Topics: Amphotericin B; Animals; Antifungal Agents; Chromatography, High Pressure Liquid; Deoxycholic Acid; Drug Combinations; Eye Diseases; Phosphatidylcholines; Phosphatidylglycerols; Rabbits; Retinal Diseases; Retinal Ganglion Cells; Vitreous Body | 2003 |
The hepatotoxicity of antifungal medications in bone marrow transplant recipients.
Topics: Adult; Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Case-Control Studies; Chemical and Drug Induced Liver Injury; Deoxycholic Acid; Drug Combinations; Female; Fluconazole; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Phosphatidylcholines; Phosphatidylglycerols; Risk Factors | 2005 |
Hepatotoxicity associated with antifungal therapy after bone marrow transplantation.
Topics: Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Chemical and Drug Induced Liver Injury; Deoxycholic Acid; Drug Combinations; Fluconazole; Humans; Phosphatidylcholines; Phosphatidylglycerols; Risk Factors | 2005 |
Deoxycholate amphotericin B and amphotericin B lipid complex exert additive antifungal activity in combination with pulmonary alveolar macrophages against Fusarium solani.
Topics: Amphotericin B; Animals; Antifungal Agents; Cells, Cultured; Deoxycholic Acid; Drug Combinations; Female; Fusarium; Humans; Macrophages, Alveolar; Phosphatidylcholines; Phosphatidylglycerols; Rabbits | 2006 |
Amphotericin B-associated hyperbilirubinemia: case report and review of the literature.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Carcinoma, Non-Small-Cell Lung; Deoxycholic Acid; Drug Combinations; Female; Humans; Hyperbilirubinemia; Liver; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols | 2006 |
Compartmentalized intrapulmonary pharmacokinetics of amphotericin B and its lipid formulations.
Topics: Amphotericin B; Animals; Antifungal Agents; Deoxycholic Acid; Drug Combinations; Female; Leukocytes, Mononuclear; Liposomes; Lung; Macrophages, Alveolar; Phosphatidylcholines; Phosphatidylglycerols; Rabbits; Tissue Distribution | 2006 |
Acrocyanosis developed with amphotericin B deoxycholate but not with amphotericin B lipid complex.
Topics: Amphotericin B; Antifungal Agents; Cyanosis; Deoxycholic Acid; Drug Combinations; Fingers; Hand; Humans; Male; Middle Aged; Mucormycosis; Phosphatidylcholines; Phosphatidylglycerols | 2007 |
CNS blastomycosis in a young man working in fields after Hurricane Katrina.
Topics: Adult; Agricultural Workers' Diseases; Amphotericin B; Antifungal Agents; Blastomyces; Blastomycosis; Brain; Cognition Disorders; Contrast Media; Deoxycholic Acid; Disasters; Drug Combinations; Encephalitis; Facial Dermatoses; Gadolinium; Humans; Itraconazole; Louisiana; Lung Diseases, Fungal; Magnetic Resonance Imaging; Male; Phosphatidylcholines; Phosphatidylglycerols; Skin Ulcer | 2007 |